Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Photo: Karwai Tang/Getty Images
The World Health Organization on Monday granted emergency authorization to the Oxford-AstraZeneca coronavirus vaccine.
Why it matters: WHO's authorization "should trigger the delivery of hundreds of millions of doses to countries that have signed up for the U.N.-backed COVAX effort, which aims to deliver vaccines to the world’s most vulnerable," AP writes.
- This is only the second vaccine to get authorization from the agency, following an emergency authorization for the BioNTech-Pfizer vaccine in December.
- The COVAX initiative, with more than 180 nation participants, is the global effort from the World Health Organization and other groups to ensure that every country has access to COVID-19 vaccines.
Details: WHO authorized two versions of the AstraZeneca vaccine — found to be approximately 63% effective.
- Due to their "easy storage requirement," the agency found them to be suitable for low- and middle-income nations.
- The vaccines will be produced by AstraZeneca-SKBio in Korea and the Serum Institute of India.
The big picture: The authorization comes days after WHO recommended the vaccine for adults ages 18 and up, including those older than 65.
- People younger than 18 should not take the vaccine, as additional research results are pending.
- WHO also recommended that "priority be given to health workers at high risk of exposure and older people."
What they're saying: "Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution," said Mariângela Simão, WHO assistant-director general for Access to Medicines and Health Products.